Biotech and Pharmaceuticals

Novo on Tuesday said its next-generation obesity drug, CagriSema, showed 25% weight loss on average among adult women…

U.S. health officials are moving ahead with a plan to allow specialty pharmacies to produce certain peptides, a…

Former drug company executive Martin Shkreli and his lead attorney Benjamin Brafman arrive at U.S. District Court for…

UnitedHealth Group signage on the floor of the New York Stock Exchange on April 21, 2025. Michael Nagle…

People who switched from obesity injections to Novo‘s new Wegovy pill continued to lose weight after three months,…

Two Indian nationals have been charged in federal court in Florida with an alleged conspiracy to smuggle counterfeit…

Eli Lilly CEO Dave Ricks told CNBC on Monday that 700,000 new seniors have started GLP-1 treatments since…

Eli Lilly CEO Dave Ricks told CNBC on Monday that one-third of new GLP-1 pill patients are taking…

People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…

Johnson & Johnson is diving head-first into the deep end of the competitive robotic surgery market. The payoff…

Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…

Gilead Bixlenvo drug Courtesy: Gilead The Food and Drug Administration approved a once-daily HIV pill from Gilead that…

Peptide drugs plan advanced by Trump administration, RFK Jr.